Effect of arc length on skin dose from hypofractionated volumetric modulated arc radiotherapy treatments of the lung and spine.


Journal

Medical dosimetry : official journal of the American Association of Medical Dosimetrists
ISSN: 1873-4022
Titre abrégé: Med Dosim
Pays: United States
ID NLM: 8908862

Informations de publication

Date de publication:
Historique:
received: 22 08 2018
revised: 01 11 2018
accepted: 06 11 2018
pubmed: 12 12 2018
medline: 15 4 2020
entrez: 12 12 2018
Statut: ppublish

Résumé

Due to large doses per fraction, stereotactic ablative radiotherapy of lung or spine can lead to skin tissue toxicity, the amount of which depends on a variety of factors such as target location, beam geometry, and immobilization. The effect of arc length on spreading out entrance and exit doses and the corresponding predictions of skin reactions has not yet been studied for stereotactic body radiotherapy volumetric modulated arc therapy (VMAT) treatments. 58 clinically relevant VMAT stereotactic body radiotherapy spine and lung plans were created for an anthropomorphic phantom utilizing a range of target locations, beam geometries and arc lengths. Skin dose was assessed by considering the National Cancer Institute skin reaction grades adjusted for 3 fraction treatments. While the skin volumes predicted to exhibit low grade reactions decreased with arc length, high grade reactions were found to increase at smaller arcs as well as at full arcs where a superposition of entrance and exit doses would occur. It is possible for skin dose to be effectively optimized by choice of arc length (within clinically relevant boundaries) and thus minimize the skin reaction. High skin doses are often attributed to effects arising from the distance between the planning target volume and patient surface but this study has demonstrated that VMAT arc length is of equal importance. Understanding this relationship will assist in minimizing skin reactions through modification of plan parameters and will provide clinicians more information for patient selection.

Identifiants

pubmed: 30528259
pii: S0958-3947(18)30132-8
doi: 10.1016/j.meddos.2018.11.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

309-314

Informations de copyright

Copyright © 2018 American Association of Medical Dosimetrists. All rights reserved.

Auteurs

James Rijken (J)

Genesis Care, Flinders Private Hospital, Bedford Park, South Australia 5042, Australia; Queensland University of Technology, Brisbane, Queensland 4000, Australia. Electronic address: james.rijken@genesiscare.com.

Tanya Kairn (T)

Queensland University of Technology, Brisbane, Queensland 4000, Australia; Royal Brisbane and Women's Hospital, Brisbane, Queensland 4000, Australia.

Scott Crowe (S)

Queensland University of Technology, Brisbane, Queensland 4000, Australia; Royal Brisbane and Women's Hospital, Brisbane, Queensland 4000, Australia.

Jamie Trapp (J)

Queensland University of Technology, Brisbane, Queensland 4000, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH